DD144057A5 - Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden nitroverbindungen - Google Patents

Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden nitroverbindungen Download PDF

Info

Publication number
DD144057A5
DD144057A5 DD79213272A DD21327279A DD144057A5 DD 144057 A5 DD144057 A5 DD 144057A5 DD 79213272 A DD79213272 A DD 79213272A DD 21327279 A DD21327279 A DD 21327279A DD 144057 A5 DD144057 A5 DD 144057A5
Authority
DD
German Democratic Republic
Prior art keywords
radical
group
nitro
lower alkyl
atom
Prior art date
Application number
DD79213272A
Other languages
German (de)
English (en)
Inventor
Michael L Roantree
Rodney C Young
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of DD144057A5 publication Critical patent/DD144057A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/12—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DD79213272A 1978-05-30 1979-05-30 Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden nitroverbindungen DD144057A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2411678 1978-05-30

Publications (1)

Publication Number Publication Date
DD144057A5 true DD144057A5 (de) 1980-09-24

Family

ID=10206649

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79213272A DD144057A5 (de) 1978-05-30 1979-05-30 Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden nitroverbindungen

Country Status (25)

Country Link
US (2) US4238493A (da)
EP (1) EP0005984B1 (da)
JP (1) JPS54157584A (da)
AR (1) AR222999A1 (da)
AT (1) AT375367B (da)
AU (1) AU522259B2 (da)
BG (1) BG31649A3 (da)
CA (1) CA1118774A (da)
CS (1) CS228116B2 (da)
DD (1) DD144057A5 (da)
DE (1) DE2965716D1 (da)
DK (1) DK223979A (da)
ES (1) ES481076A1 (da)
FI (1) FI791737A7 (da)
GR (1) GR68500B (da)
HU (1) HU181960B (da)
IE (1) IE48510B1 (da)
IL (1) IL57416A (da)
NO (1) NO151322C (da)
PL (1) PL117921B1 (da)
PT (1) PT69686A (da)
RO (1) RO78154A (da)
SU (1) SU888815A3 (da)
YU (1) YU127179A (da)
ZA (1) ZA792608B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028482A1 (en) * 1979-10-24 1981-05-13 Smith Kline & French Laboratories Limited Guanidine compounds, process for preparing them and compositions containing them

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405624A (en) * 1978-05-30 1983-09-20 Smith Kline & French Laboratories Limited Nitro-substituted dihydropyrroles and tetrahydropyridines, compositions, compounds, and medicinal use
ZA792608B (en) * 1978-05-30 1980-06-25 Smith Kline French Lab Nitro compounds
PT72320B (en) * 1980-01-08 1982-07-23 Glaxo Group Ltd Process for preparation of a furan derivative
US4350696A (en) * 1980-03-08 1982-09-21 Pfizer Inc. Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
US4439437A (en) * 1981-04-28 1984-03-27 Smith Kline & French Laboratories Limited 2-[2-Thiazolyl or 2-guanidino-4-thiazolyl methylthioethyl(or butyl)amino]-3-(hydroxy or carboxy)pyridines, compositions containing same and method of use
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
US4525477A (en) * 1981-12-02 1985-06-25 Smith Kline & French Laboratories Limited 2-Thiazolyl, isothiazolyl, oxazolyl and isoxazolyl alkylamino-3-nitro-heterocyclic compounds
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
GR82004B (da) * 1983-06-30 1984-12-12 American Home Prod
IN170284B (da) * 1988-10-26 1992-03-07 Takeda Chemical Industries Ltd
EP0375613A3 (de) * 1988-12-21 1990-11-28 Ciba-Geigy Ag Nitroenamine
US6133291A (en) * 1998-10-16 2000-10-17 Schering Corporation N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1223686A (en) 1967-02-24 1971-03-03 Ici Ltd Salts of pyrimidine derivatives and the use thereof as fungicides
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
DE1617705C3 (de) * 1966-12-19 1973-10-11 Oreal Kosmetisches Mittel fur die Haar behandlung
US3518251A (en) * 1967-06-07 1970-06-30 Geigy Ag J R Certain aminoalkylamino substituted azacycloalkenes
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
US3905984A (en) * 1971-03-09 1975-09-16 Smith Kline French Lab Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas
US3950353A (en) * 1971-03-09 1976-04-13 Smith Kline & French Laboratories Limited Pharmacologically active thiourea and urea compounds
US3920822A (en) * 1972-09-05 1975-11-18 Smith Kline French Lab Inhibition of histamine activity with cyanoguanidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4005205A (en) * 1974-04-24 1977-01-25 Smith Kline & French Laboratories Limited Compositions and methods for inhibiting H2 histamine receptors
CH595061A5 (da) * 1974-05-10 1978-01-31 Ciba Geigy Ag
US4166856A (en) * 1975-05-21 1979-09-04 Smith Kline & French Laboratories Limited Thiazole and isothiazole derivative as blockers of histamine H2 -receptors
GB1563090A (en) * 1975-07-31 1980-03-19 Smith Kline French Lab Cyclobutene-diones
IN146736B (da) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
DE2752820A1 (de) * 1977-11-26 1979-05-31 Bayer Ag Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4297498A (en) * 1978-01-30 1981-10-27 Mead Johnson & Company 4-Tertiary-amino-2,6-diaminopyridine 1-oxides
ZA792608B (en) * 1978-05-30 1980-06-25 Smith Kline French Lab Nitro compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028482A1 (en) * 1979-10-24 1981-05-13 Smith Kline & French Laboratories Limited Guanidine compounds, process for preparing them and compositions containing them

Also Published As

Publication number Publication date
EP0005984B1 (en) 1983-06-22
RO78154A (ro) 1982-02-01
US4656176A (en) 1987-04-07
PT69686A (en) 1979-06-01
HU181960B (en) 1983-11-28
IL57416A (en) 1983-03-31
CA1118774A (en) 1982-02-23
US4238493A (en) 1980-12-09
IE48510B1 (en) 1985-02-20
CS228116B2 (en) 1984-05-14
ZA792608B (en) 1980-06-25
IE791099L (en) 1979-11-30
NO791763L (no) 1979-12-03
NO151322C (no) 1985-03-20
NO151322B (no) 1984-12-10
ATA395179A (de) 1983-12-15
BG31649A3 (bg) 1982-02-15
AT375367B (de) 1984-07-25
IL57416A0 (en) 1979-09-30
DK223979A (da) 1979-12-01
AU522259B2 (en) 1982-05-27
EP0005984A1 (en) 1979-12-12
PL117921B1 (en) 1981-09-30
YU127179A (en) 1983-01-21
AU4758079A (en) 1979-12-06
GR68500B (da) 1982-01-07
JPS54157584A (en) 1979-12-12
DE2965716D1 (en) 1983-07-28
FI791737A7 (fi) 1981-01-01
ES481076A1 (es) 1980-02-01
PL215970A1 (da) 1980-02-11
SU888815A3 (ru) 1981-12-07
AR222999A1 (es) 1981-07-15

Similar Documents

Publication Publication Date Title
DE2951675C2 (de) Guanidinothiazolverbindungen, Verfahren zu deren Herstellung und Arzneimittelzubereitungen
DD144057A5 (de) Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden nitroverbindungen
DE2734070A1 (de) Aminoalkylfuranderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2421548A1 (de) Amine und ihre salze, verfahren zu ihrer herstellung und arzneimittel
CH649527A5 (de) 1,2-diaminocyclobuten-3,4-dione, verfahren zu deren herstellung und pharmazeutische mittel, die diese verbindungen enthalten.
CH615669A5 (da)
DE2423813A1 (de) 1,1-diaminoaethylenderivate, ihre salze, verfahren zu ihrer herstellung und arzneimittel
DE2821409A1 (de) Aminoalkylthiophenverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DD144055A5 (de) Verfahren zur herstellung neuer aminothiazole
DD233374A5 (de) Verfahren zur herstellung von 2-(n-subst.-guanidino)-4-heteroarylthiazole
DE2433625A1 (de) Harnstoff-derivate, verfahren zu ihrer herstellung und arzneimittel
DE2322880A1 (de) Neue organische verbindungen und verfahren zu deren herstellung
DE2847792C2 (da)
DE2344833A1 (de) Guanidine, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2950838A1 (de) Neue thiazolylmethylthioderivate, verfahren zu deren herstellung und arzneimittel
DE2510860A1 (de) Harnstoff-derivate, verfahren zu ihrer herstellung und arzneimittel
DD144056A5 (de) Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden nitroverbindungen
DE2819874A1 (de) Bisamidine, verfahren zu ihrer herstellung und ihre verwendung als histamin- h tief 2 - receptor-antagonisten
AT390952B (de) Verfahren zur herstellung von neuen furan- oder thiophenderivaten
CH652401A5 (de) Amino-2,1,3-benzothiadiazol- und -benzoxadiazol-derivate, ihre herstellung und sie enthaltende arzneimittel.
DE3537715C2 (da)
EP0160173B1 (de) Benzothiazolderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltendes Arzneimittel
CH624387A5 (da)
EP0154721A1 (de) Neue Alkanolderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltendes Arzneimittel
DE2403416C2 (de) 1-Phenylimidazol-Derivate, ihre Salze, Verfahren zu ihrer Herstellung und ihre Verwendung